CORD Webinar 4 – From Readiness to Action: The Capstone Consultation Before the Rare Readiness Scorecard Launch
CPD-Accredited Webinar | Neuromuscular Mystery Case Rounds
FSHD Canada Foundation – The 2026 Alberta Walk & Roll to Cure FSHD
Clinical Trial Personnel Community of Practice Educational Sharing Session: Canadian Clinical Trial Startups: Critical Local Considerations and Risk Reduction
Physiotherapy and Occupational Therapy Community of Practice Knowledge Sharing Session – Respiratory Health and Treatments for DMD and SMA presented
CORD Webinar 4 – From Readiness to Action: The Capstone Consultation Before the Rare Readiness Scorecard Launch
Final Webinar in CORD’s 4-Part Summer Rare Disease Readiness Series
Date: Tuesday, August 11, 2026
Time: 12:00 PM to 1:15 PM ET
(Core program: 12:00 to 1:00 PM | Optional discussion: 1:00 to 1:15 PM)
Join the Canadian Organization for Rare Disorders for an interactive consultation to help shape Canada’s Rare Readiness Scorecard. Through discussion, case studies, and audience input, participants will explore what readiness should look like and identify priorities for improving rare disease care and access. Visit the event website for more information.
Click to view overview of the event
Overview
Canada has made important progress in rare disease diagnosis, treatment and access, but how well does the system work for patients in practice?
Join CORD for the final webinar in our 4 Part Summer Rare Disease Readiness Series, an interactive consultation that will help shape the forthcoming Rare Readiness Scorecard.
Using ATTR cardiomyopathy and spinal muscular atrophy as case studies, a live panel of patients and caregivers, health professionals, policy experts, data specialists and industry representatives, together with audience participants, will assess Canada’s readiness across:
• Recognition, diagnosis and referral
• Timely and equitable treatment access
• Provincial implementation
• Integrated care
• Data, outcomes and accountability
• Priorities for the next phase of the Rare Disease Drug Strategy
Through live polling and discussion, you’ll help identify what Canada should measure, where the biggest gaps remain, and what actions are needed to improve patient access.
Your voice matters. The findings will help refine national, provincial and disease specific Rare Readiness Scorecards and inform recommendations for RDDS Phase 2.
